Brief: EQL Pharma Q4 EBIT SEK 23 Million
08/05/2025 06:00
May 08 (Reuters) - EQL Pharma Q4 adjusted free cash flow SEK -13.9 million. Q4 revenue SEK 113.3 million Q4 EBIT margin 20%
EQL — EQL Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m